Tinnitus group Neuromod raises €30m to fund drive into US market

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 77%

Business News News

Business Business Latest News,Business Business Headlines

Irish medtech Neuromod Devices has raised €30 million to fund expansion into the US market after FDA approval of it tinnitus therapy ...and its first target are 2.7 million US army veterans.

“But there is almost twice that with tinnitus – 2.7 million veterans – and they have nothing for them,” Dr O’Neill said. He added that, at present, compensation to this group is costing the US about $4.9 billion a year.

The latest funding – which more than doubles the money the NUI Maynooth spin-out has raised since it was founded in 2010 – is split evenly between venture debt funding from the European Investment Bank and new equity investment. The equity investment was led by a new shareholder, Italian life sciences specialist Panakès, but also includes the company’s existing shareholders.

“We have continued to have the complete support of all of our long-term investors and now Panakès has joined that group as well,” said Dr O’Neill.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Neuromod raises €30m to fund drive into US marketCompany’s Lenire device approved by FDA uses sound and electric stimulation to ease symptoms of tinnitus
Source: IrishTimesBiz - 🏆 6. / 77 Read more »

Neuromod fundraising, office market slump, proxy adviser backs Kingspan’s MurtaghBusiness Today: the best news, analysis and comment from The Irish Times business desk
Source: IrishTimes - 🏆 3. / 98 Read more »